The Ultimate Growth Stock to Buy With $1,000 Right Now

Ulta Beauty reported fiscal Q1 same-store sales growth of 2.9% (driven 2.3 percentage points by higher spend and the balance by traffic) and modestly raised full-year comp guidance to 0–1.5% from 0–1%, signaling resilient demand amid macro uncertainty. The company is pursuing expansion — about 1,450 stores after Q1 with roughly 54 additional openings planned this year — and remains under 10% share of a roughly $120 billion U.S. beauty market, indicating material long-term runway. Shares have risen ~20.4% over the past year through May 30 while trading at roughly a 16x P/E versus the S&P 500’s ~28x; management’s conservative FY EPS guidance of $22.65–$23.20 (down from $25.34 last year) tempers near-term expectations but could present a patient investor opportunity. The Motley Fool discloses it holds and recommends Ulta but did not include the stock in its current top-10 picks.

Analysis

Ulta Beauty reported fiscal first-quarter same-store sales (comps) growth of 2.9% for the period ended May 3, with 2.3 percentage points attributable to higher spending and the remainder to traffic; management modestly raised full-year comp guidance to 0.0%–1.5% from 0.0%–1.0%, signaling resilience against a backdrop of macro uncertainty. The company finished the quarter with roughly 1,450 stores after opening six locations and plans to add about 54 more sites this year, following openings of 30 and 60 stores in fiscal 2023 and 2024, respectively, which underscores management’s confidence in expansion as the growth lever. Ulta still controls under 10% of an estimated $120 billion U.S. beauty market, implying meaningful addressable-market upside even if near-term demand is muted. Shares have risen ~20.4% over the past year through May 30 while trading at an implied P/E near 16 versus the S&P 500’s ~28; management’s FY diluted EPS guidance of $22.65–$23.20 (down from $25.34 last year) reflects conservative near-term expectations and creates a valuation entry point for patient investors. Investors should weigh the upside from store expansion and market share gains against downside risks from softer consumer spending, margin pressure, and the reputational/conflict disclosures noted in the article.

Key Decisions for Investors

• Consider a patient accumulation strategy (e.g., dollar-cost averaging) given a ~16x P/E, long runway under 10% market share, and conservative FY EPS guidance which may limit near-term downside,
• Monitor monthly/quarterly comps details (traffic versus ticket), FY guidance revisions, and margin trends closely and trim or hedge positions if comps or EPS guidance deteriorate materially,
• Evaluate new-store unit economics and same-store sales contribution from openings; pause add-on exposure if store productivity or incremental capex/lease costs weaken,
• Factor in the article’s disclosure that The Motley Fool holds and recommends ULTA and that ULTA was not in its top-10 list; seek corroborating analyst views before increasing position size